Pazopanib Terminated Phase 4 Trials for metastatic Clear Cell Renal Cell Carcinoma (ccRCC) Basic Science
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Basic Science | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02570789 | Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy |